0001209191-22-060278.txt : 20221207
0001209191-22-060278.hdr.sgml : 20221207
20221207200602
ACCESSION NUMBER: 0001209191-22-060278
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221205
FILED AS OF DATE: 20221207
DATE AS OF CHANGE: 20221207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Charlton Ralph William III
CENTRAL INDEX KEY: 0001919397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 221451252
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BOULEVARD, SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 294-1687
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-05
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001919397
Charlton Ralph William III
C/O SPRUCE BIOSCIENCES, INC.
2001 JUNIPERO SERRA BOULEVARD, SUITE 640
DALY CITY
CA
94104
0
1
0
0
Chief Medical Officer
Restricted Stock Units
0.00
2022-12-05
4
A
0
127000
0.00
A
Common Stock
127000
127000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
The RSUs vest over four years. 25% of the RSUs will vest on December 15, 2023 (the "Annual Vesting Date"), and 25% of the total number of RSUs will vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
/s/ Samir Gharib, Attorney-in-Fact
2022-12-07